Inflammatory bowel diseases (IBD) are characterized by recurrent inflammation in the gastrointestinal tract. Infiltration of CD4+ lymphocytes and neutrophils is one of the predominant features in IBD. Recently, interleukin (IL)-23 and the downstream T-cell derived cytokine IL-17 have been found to be elevated in IBD patients. However, the role of IL-17 and IL-17 receptor (IL-17R) signaling in gastrointestinal inflammation is unknown. To examine their role, we investigated colonic inflammation in wild-type or IL-17R KO mice. Using a model of TNBS-induced colitis, we found that IL-17 was produced in colon tissue at 24 and 48 hours. IL-17R KO mice were significantly protected against TNBS-induced weight loss, IL-6 production, local MIP-2 induction, as well as colonic inflammation. This protection occurred in the presence of equivalent induction of local IL-23 and higher levels of IL-12p70 and IFN-gamma in IL-17R KO mice compared to wild-type mice. Moreover, IL-17R KO mice exhibited a reduced tissue neutrophil infiltration as assessed by myeloperoxidase activity. Furthermore, overexpression of an IL-17R IgG1 fusion protein significantly attenuated colonic inflammation after TNBS challenge. These results demonstrate that IL-17 and IL-17R signaling play a critical role in the development of TNBS-induced colitis and may represent a target for therapeutic intervention for IBD.
Conclusion:We have for the first time directly measured the force generated by HSCs after a range of days in culture. Both the force of contraction and the number of cells within a cross-section of a gel increased with the number of days in culture. This suggests that the time-dependent increase in force generation may be due to an increase in HSC number rather than an increase in force generated by each cell.
Inflammatory bowel diseases (IBD) are characterized by recurrent inflammation in the gastrointestinal tract. Infiltration of CD4+ lymphocytes and neutrophils is one of the predominant features in IBD. Recently, interleukin (IL)-23 and the downstream T-cell derived cytokine IL-17 have been found to be elevated in IBD patients. However, the role of IL-17 and IL-17 receptor (IL-17R) signaling in gastrointestinal inflammation is unknown. To examine their role, we investigated colonic inflammation in wild-type or IL-17R KO mice. Using a model of TNBS-induced colitis, we found that IL-17 was produced in colon tissue at 24 and 48 hours. IL-17R KO mice were significantly protected against TNBS-induced weight loss, IL-6 production, local MIP-2 induction, as well as colonic inflammation. This protection occurred in the presence of equivalent induction of local IL-23 and higher levels of IL-12p70 and IFN-gamma in IL-17R KO mice compared to wild-type mice. Moreover, IL-17R KO mice exhibited a reduced tissue neutrophil infiltration as assessed by myeloperoxidase activity. Furthermore, overexpression of an IL-17R IgG1 fusion protein significantly attenuated colonic inflammation after TNBS challenge. These results demonstrate that IL-17 and IL-17R signaling play a critical role in the development of TNBS-induced colitis and may represent a target for therapeutic intervention for IBD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.